Innovator IBD 50 ETF (NYSEARCA:FFTY) Trading Up 1.1% – Here’s Why

Innovator IBD 50 ETF (NYSEARCA:FFTY)’s stock price rose 1.1% during trading on Thursday . The stock traded as high as $42.65 and last traded at $42.29. Approximately 42,567 shares changed hands during mid-day trading, a decline of 44% from the average daily volume of 75,524 shares. The stock had previously closed at $41.81.

Innovator IBD 50 ETF Stock Down 7.5%

The business’s 50 day simple moving average is $38.07 and its two-hundred day simple moving average is $37.08. The stock has a market cap of $90.00 million, a P/E ratio of 30.34 and a beta of 1.47.

Hedge Funds Weigh In On Innovator IBD 50 ETF

Institutional investors and hedge funds have recently bought and sold shares of the company. AlphaCore Capital LLC bought a new stake in shares of Innovator IBD 50 ETF during the fourth quarter worth about $32,000. International Assets Investment Management LLC bought a new stake in Innovator IBD 50 ETF during the 4th quarter worth approximately $35,000. Advisory Services Network LLC bought a new stake in Innovator IBD 50 ETF during the 3rd quarter worth approximately $43,000. Simplex Trading LLC acquired a new position in Innovator IBD 50 ETF in the 4th quarter valued at approximately $41,000. Finally, Kestra Advisory Services LLC acquired a new position in Innovator IBD 50 ETF in the 4th quarter valued at approximately $72,000.

Innovator IBD 50 ETF Company Profile

The Innovator IBD 50 ETF (FFTY) is an exchange-traded fund that is based on the IBD 50 index. The fund tracks an index of 50 US-listed stocks with aggressive growth characteristics. Holdings are selected based on fundamental and technical rankings FFTY was launched on Apr 9, 2015 and is managed by Innovator.